Amping up T cells to target cancer
Vaccines that turn the body’s immune system against tumors have shown promise in clinical trials, and a handful have been FDA approved for certain cancers. In many patients, however, these vaccines don’t stimulate enough of a response, and the approach some researchers have taken to strengthening it - delivering the vaccine along with immune-stimulating molecules called cytokines - can cause severe side effects. Now MIT chemical engineer Daniel Anderson and colleagues at MIT, Harvard, and the Un
The tech section covers stories about technology making life better, not just more profitable. Open-source tools reaching new audiences, accessibility breakthroughs, AI applications in healthcare and education, infrastructure improvements that quietly make cities work better. Product launches and funding rounds are excluded unless they deliver tangible public benefit.
Good news deserves a clean reading experience. AdGuard blocks ads, trackers, and malware across all your devices so you can focus on what matters.
Try AdGuard →Robot Olympics ends with humanoid's 8.64-second 100m, nearly a second faster than Bolt Reuters
An interdisciplinary team of researchers has developed and demonstrated a step-by-step framework called Socratic Challen…
Machine learning doesn't replace human intelligence, but it can outlast human endurance, which makes it a helpful tool f…
Researchers affiliated with UTHealth Houston, competing under the team name Novamab AI, placed among the top five teams …
Most news feeds won't give you another one. Our morning letter will: one email at sunrise with the day's best good news.
Start tomorrow morning →